risks of glp-1 medications linked to major drop in pancreatic, colorectal cancer risk https://www.medicalnewstoday.com/articles/weight-loss-drugs-glp-1-slash-risk -4-types-cancer-50-or-more-study Why do patients stop GLP-1

While multiple studies have said there is data suggesting benefits from semaglutide, others have also found risks

Parting Thoughts on Nausea on GLP-1 Nausea from slower digestion, brain effects, and increased satiety come with the territory of GLP-1 drugs

To resolve this issue, the researchers investigated whether anti-obesity probiotic strains could enhance weight loss from GLP-1 drugs and decrease weight regain

PMID: 13 Pi-SunyerXAstrupAFujiokaKGreenwayFHalpernAKrempfMet al

To view or add a comment, sign in Great update for health care in India The Supreme Court dismissed Roche's appeal, allowing Natco Pharma to sell a much cheaper generic version of the spinal muscular atrophy drug Risdiplam in India